RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 84.30
-0.15 (-0.18%)
Nov 20, 2025, 9:29 AM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 51.05 billion as of November 19, 2025. Its market cap has increased by 254.73% in one year.
Market Cap
51.05B
Enterprise Value
52.15B
Revenue
2.43B
Ranking
n/a
PE Ratio
n/a
Stock Price
84.30
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 51.05B, an increase of 52.90%. That is a compound annual growth rate of 8.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 51.05B | 264.54% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | 46.53B | 39.37% |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 313.45B |
| Hansoh Pharmaceutical Group Company | 236.23B |
| JD Health International | 214.50B |
| Innovent Biologics | 154.92B |
| WuXi Biologics | 130.87B |
| Sino Biopharmaceutical | 124.78B |
| Akeso | 103.08B |
| Sichuan Kelun-Biotech Biopharmaceutical | 101.34B |